TABLE 2.
Variables | β‐coefficient | 95% CI | p value |
---|---|---|---|
T‐Worsening | 0.61 | 0.53, 0.69 | <0.001 |
T‐Reintroduction | 0.07 | −0.01, 0.14 | 0.069 |
T‐Baseline | 0.6 | 0.52, 0.69 | <0.001 |
Migraine type: CM | 0.09 | 0.00, 0.18 | 0.048 |
NSAIDs overuse | 0.02 | 0.01, 0.02 | <0.001 |
Opioids overuse | 0 | −0.01, 0.02 | 0.669 |
Triptans overuse | 0.04 | 0.03, 0.04 | <0.001 |
Abbreviations: CI, confidence interval; CM, chronic migraine; NSAIDs, nonsteroidal anti‐inflammatory drugs; T‐Baseline, month before initiating anti‐CGRP MAb treatment; T‐Worsening, last month before the resumption of treatment; T‐Reintroduction, the third month after anti‐CGRP MAb reintroduction.